Introduction: Systemic Lupus Erythematosus is an autoimmune disease with systemic multiorgan involvement that requires continuous follow-up to control the clinical course of the disease. Based on the current problems in our country, this paper aims to highlight the role of Hydroxychloroquine as a highly effective immunosuppressive therapy in the treatment of SLE and the hematological complications that are caused.